NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NAVCO Pharmaceuticals Inc., a company specializing in nanotechnology for health products, has granted 3.9 million stock options to its officers, directors, and consultants at $0.05 per share, exercisable over ten years. These options, part of the company’s 2018 stock option plan, vest immediately to aid in the growth of NAVCO, which is focused on innovative defenses against pathogens in various markets, including human health and veterinary services.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.